Johnson & Johnson (JNJ) short interest & options flow
BASEJohnson & Johnson has done something quietly remarkable this week: it has rallied far enough that the stock now trades above every single price at which its executives have sold over the past three weeks. The insider theme that dominated the last two notes has not resolved — it has simply been outrun by the tape. CEO Joaquin Duato disposed of roughly $44.7 million worth of stock…
- Market cap
- $664.95B
- Next earnings
- 19 Jan 2027
Key data as of 9 Nov 2026

JNJ Stock Report — available now on ORTEX
A new long-form analysis for JNJ this week — anomalies vs the company's own history, peer comparisons, news context, and the full data picture. Premium subscribers only.
Read on ORTEX →Sign up for premiumJNJ news and analysis
RSSNo long-form analysis yet for JNJ. Pulse alerts and the live data picture are available on ORTEX.
Open JNJ on ORTEX →Want the live picture for JNJ?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for JNJ — free to start on ORTEX.
Sign up for free →Open JNJ on ORTEX